
Sign up to save your podcasts
Or


Sepsis kills 11 million people a year globally, often because early symptoms look like the flu. But a new wave of hospital AI systems—trained on continuous vital-sign streams from wearable sensors—is catching it three to six hours before traditional screening tools. In this episode, we dive into the specific algorithms running at Johns Hopkins and the UK's NHS, how they combine heart rate variability, respiratory rate, and temperature trends into a single risk score, and why doctors still hesitate to trust a machine's warning over their own instincts. We also explore the tension between faster detection and alert fatigue—a real problem when the AI flags 40 percent of patients as at risk. No hype, just the numbers: false positive rates, time saved, and what it means for the future of hospital monitoring.
#SepsisDetection #AIinHealthcare #WearableSensors #HospitalAI #HealthTech #MachineLearning #JohnsHopkins #NHS #VitalSigns #PredictiveAnalytics #PatientSafety #ClinicalAI #AlertFatigue #HealthInnovation #DigitalHealth #Business #FexingoBusiness #BusinessPodcast
Keep every episode free: buymeacoffee.com/fexingo
Continuous glucose monitors were once the exclusive domain of the insulin-dependent diabetic. But in 2026, a wave of consumer-facing CGM companies is marketing them to biohackers, gym-goers, and the simply curious. In this episode, Lucas and Luna look at the numbers behind the shift — from clinical utility to lifestyle gadget. They break down the promise of metabolic insight, the skepticism from the medical establishment, and the thin line between health optimization and health anxiety. Featuring a closer look at the startup Nutrisense, which aims to build a CGM-based nutrition coaching subscription, and the FDA's evolving stance on over-the-counter wearable sensors. Is this the blood-pressure-cuff moment for glucose, or the wellness industry's next overhyped panel?
#ContinuousGlucoseMonitor #CGM #Nutrisense #WearableTech #DigitalHealth #MetabolicHealth #Biohacking #Wellness #GlucoseMonitoring #FDA #OverTheCounter #HealthTech #BloodSugar #Nutrition #FexingoBusiness #BusinessPodcast #Business #Technology
Keep every episode free: buymeacoffee.com/fexingo
In this episode of The Digital Health Podcast, Lucas and Luna explore how artificial intelligence is transforming microbiome analysis. They focus on a specific startup, Viome, which uses RNA sequencing and AI to provide personalized dietary recommendations from a single stool sample. The discussion covers the technology behind metatranscriptomics, how it differs from traditional DNA sequencing, and why this matters for conditions like irritable bowel syndrome and metabolic health. Lucas explains the shift from generic probiotics to targeted interventions, while Luna questions the evidence base and the regulatory path. They also touch on the business model — subscription-based testing — and the challenge of turning complex microbiome data into actionable advice. The episode includes a brief, organic donation segment acknowledging listener support that keeps the show ad-free. Whether you're a health-tech operator or a curious patient, this episode offers a concrete look at how AI is decoding one of the most complex ecosystems in the human body.
#Microbiome #AI #Viome #RNASequencing #Metatranscriptomics #DigitalHealth #GutHealth #PersonalizedMedicine #Probiotics #MetabolicHealth #IBD #StoolTest #HealthTech #Bioinformatics #Startup #Business #FexingoBusiness #BusinessPodcast
Keep every episode free: buymeacoffee.com/fexingo
Digital twins — virtual replicas of human organs, systems, or even entire bodies — are moving from engineering into medicine. In this episode, Lucas and Luna explore how Dassault Systèmes built a 3D heart model accurate enough to simulate surgical outcomes, and why cardiologists at Boston Children's Hospital are using it to plan complex procedures before entering the OR. They discuss the computational scale (each heart model requires over 100 million data points), the regulatory puzzle (the FDA has approved exactly zero digital twins for clinical use), and the ethical tension: what happens when the simulation disagrees with the doctor? Specific, grounded, and forward-looking — no hype.
#DigitalTwins #HealthTech #DassaultSystemes #BostonChildrensHospital #Cardiology #MedicalSimulation #SurgicalPlanning #FDA #ComputationalMedicine #3DModeling #VirtualHeart #HealthcareInnovation #PrecisionMedicine #OrganSimulation #Business #Technology #FexingoBusiness #BusinessPodcast
Keep every episode free: buymeacoffee.com/fexingo
Episode 53 of The Digital Health Podcast explores the emerging field of digital therapeutics for chronic pain. Lucas and Luna examine how companies like Kaia Health and DarioHealth are using cognitive behavioral therapy, movement tracking, and biofeedback to manage conditions like back pain and fibromyalgia—often replacing or reducing opioid use. They discuss a randomized controlled trial showing a 35% reduction in pain-related disability for users of a prescription digital therapeutic, and what this means for insurers and employers seeking non-pharmacological alternatives. The hosts also weigh the regulatory challenges, including FDA clearance for software-as-a-medical-device, and why some clinicians remain skeptical. A thoughtful look at how software is becoming a legitimate treatment modality for one of medicine's most intractable problems: chronic pain.
#DigitalHealth #ChronicPain #DigitalTherapeutics #KaiaHealth #DarioHealth #OpioidCrisis #CognitiveBehavioralTherapy #Biofeedback #FDA #SaMD #Business #Healthcare #FexingoBusiness #BusinessPodcast #Podcast #HealthTech #PainManagement #NonOpioid
Keep every episode free: buymeacoffee.com/fexingo
Lucas and Luna explore how startups like Nabla and Abridge are deploying generative AI to automate clinical documentation, cutting physician note-taking time from hours to minutes. They examine the accuracy trade-offs, the integration challenges with existing EHR systems, and why this technology might actually reduce burnout rather than just add another tool. With specific examples from pilot programs at Nuance and Epic, the hosts discuss whether AI-generated notes can pass the 'chart review' test and how HIPAA compliance is shaping the market. Plus: what it means for patients who want to understand their own records.
#GenerativeAI #ClinicalNotes #Nabla #Abridge #Nuance #Epic #EHR #HealthTech #Startups #Burnout #HIPAA #MedicalDocumentation #AIinHealthcare #DigitalHealth #FexingoBusiness #BusinessPodcast #Technology #FutureOfMedicine
Keep every episode free: buymeacoffee.com/fexingo
Lucas and Luna explore how continuous glucose monitors are moving from a niche diabetes tool to a mainstream wellness device for athletes, biohackers, and the general public. They examine the science behind CGMs, the key players like Abbott and Dexcom, the controversy over using them without medical need, and what the data really shows about glucose variability in non-diabetics. Specific focus on the 2024-2025 boom in prescription-free CGM access through companies like Levels and Nutrisense, and the emerging evidence on personalized nutrition responses. The episode also touches on the FDA's evolving stance and the economics of a potential mass market for wearable biosensors.
#ContinuousGlucoseMonitor #CGM #WearableTech #DigitalHealth #Diabetes #Biohacking #Abbott #Dexcom #Levels #Nutrisense #GlucoseMonitoring #HealthTech #Wearables #PersonalizedNutrition #FDA #Business #FexingoBusiness #BusinessPodcast
Keep every episode free: buymeacoffee.com/fexingo
Episode 50 of The Digital Health Podcast explores how life and health insurers are using data from wearables like smartwatches and fitness trackers to inform underwriting decisions. Lucas and Luna examine the case of John Hancock, which in 2018 became the first major US life insurer to offer interactive policies tied to wearable data through its Vitality program. They discuss how this shift from reactive claims processing to continuous risk monitoring is reshaping the insurance industry, the privacy concerns it raises, and what it means for consumers who choose to share their step counts, sleep scores, and heart rate data for potential premium discounts. The episode also touches on regulatory scrutiny from state insurance commissioners and the growing market for data brokers specializing in health metrics. If you're building or running a business at the intersection of health tech and insurance, this episode offers a concrete look at how one data stream is changing a trillion-dollar industry.
#WearableData #HealthInsurance #LifeInsurance #Underwriting #JohnHancock #VitalityProgram #InsuranceTech #DataPrivacy #ConsumerHealth #Smartwatch #FitnessTracker #RiskAssessment #BehavioralInsurance #DigitalHealth #Business #Technology #FexingoBusiness #BusinessPodcast
Keep every episode free: buymeacoffee.com/fexingo
Episode 49 of The Digital Health Podcast with Fexingo. Lucas and Luna explore the quietly growing market where health insurers pay for wearable device data — not through employer wellness programs, but via direct incentives, premium discounts, and data-sharing agreements. They break down the specific case of UnitedHealth's Motion program, which offers up to $1,000 per year in rewards for sharing step counts and heart rate data from devices like Garmin and Fitbit. The hosts discuss the privacy trade-offs, the regulatory gray area under HIPAA, and how startups like Vivante Health are building insurance-linked digital health platforms. They also examine why Apple and Google are designing their health APIs to give users granular control over data sharing — and whether that's enough to prevent risk-based pricing. A sharp, skeptical conversation about the monetization of personal health data, without sensationalism.
#WearableData #HealthInsurance #UnitedHealth #MotionProgram #Garmin #Fitbit #AppleHealth #DataPrivacy #DigitalHealth #Insurtech #VivanteHealth #HIPAA #PremiumDiscounts #HealthPolicy #Business #FexingoBusiness #BusinessPodcast #TechAndHealth
Keep every episode free: buymeacoffee.com/fexingo
Episode 48 of The Digital Health Podcast explores how smartphone photos and computer vision are transforming skin cancer screening. Lucas and Luna break down the FDA-cleared AI from companies like SkinAnalytics and DermTech, the accuracy numbers from a 2025 JAMA Dermatology study, and why dermatologists are split between excitement and skepticism. They discuss how convolutional neural networks trained on millions of dermoscopic images can now detect melanoma with sensitivity above 95 percent, but also the real-world pitfalls like lighting variation and skin tone bias. The hosts talk about the specific workflow at Kaiser Permanente's teledermatology program, where patients upload moles for AI triage before seeing a specialist. A concrete, numbers-driven look at a technology that could shift dermatology from reactive to proactive care.
#SkinCancer #AI #ComputerVision #Dermatology #Melanoma #HealthTech #DigitalHealth #FDA #Teledermatology #JAMA #SkinAnalytics #DermTech #KaiserPermanente #MachineLearning #CNN #Business #Technology #FexingoBusiness
Keep every episode free: buymeacoffee.com/fexingo
From the publisher's feed